Johnson & Johnson (JNJ)
243.47
-1.70
(-0.69%)
USD |
NYSE |
Feb 26, 16:00
243.18
-0.29
(-0.12%)
Pre-Market: 07:36
Johnson & Johnson Free Cash Flow : 19.70B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Gilead Sciences, Inc. | 9.456B |
| Eli Lilly & Co. | 5.964B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.309B |
| Cash from Investing (Quarterly) | -4.485B |
| Cash from Financing (Quarterly) | -1.369B |
| Free Cash Flow Per Share (Quarterly) | 2.401 |
| Free Cash Flow to Equity (Quarterly) | 2.319B |
| Free Cash Flow to Firm (Quarterly) | 6.362B |
| Free Cash Flow Yield | 3.33% |